Outlook Therapeutics Soars 12.32% in Pre-Market Trading

On May 15, 2025, Outlook Therapeutics' stock surged by 12.32% in pre-market trading, reflecting a significant upward momentum.

Analysts have set a wide range of price targets for Outlook Therapeutics, with estimates varying from a low of $3.00 to a high of $24.00 over the next 12 months. This broad range indicates a high degree of uncertainty and potential volatility in the stock's future performance.

Despite the recent surge, some analysts predict a short-term decline. The stock is expected to fall by 2.49% over the next three months, with a 90% probability of holding a price between $1.09 and $1.59. This forecast suggests that while the stock may experience short-term fluctuations, it could stabilize within a specific range.

Outlook Therapeutics' market capitalization stands at $66.21 million USD, positioning it as the 9349th most valuable company globally. This valuation reflects the company's current market standing and potential for growth.